Burning Rock Biotech Limited

LSE:BNR Stock Report

Market Cap: US$33.1m

Burning Rock Biotech Balance Sheet Health

Financial Health criteria checks 6/6

Burning Rock Biotech has a total shareholder equity of CN¥677.8M and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.0B and CN¥345.5M respectively.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ration/a
CashCN¥532.54m
EquityCN¥677.85m
Total liabilitiesCN¥345.54m
Total assetsCN¥1.02b

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: BNR's short term assets (CN¥806.3M) exceed its short term liabilities (CN¥259.6M).

Long Term Liabilities: BNR's short term assets (CN¥806.3M) exceed its long term liabilities (CN¥85.9M).


Debt to Equity History and Analysis

Debt Level: BNR is debt free.

Reducing Debt: BNR has no debt compared to 5 years ago when its debt to equity ratio was 26.2%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BNR has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: BNR has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 12.3% each year.


Discover healthy companies